'Drug administration fda approved' presentation slideshows

Drug Development:

Drug Development:. Nilotinib. Mak Shu Ting (18) Yip Pui Yue (29). Introduction. a tyrosine kinase inhibitor used targeted therapy for blood cancer , Chronic myelocytic leukemia (CML) Bcr-Abl protein Blocks the signals f rom these proteins

141 views • 8 slides

Science & Technology

171 views • 5 slides

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Set to Expand Saliently at a Robust CAGR during the Forecast

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease and motor neuron disease (MND), is a neurodegenerative disease, affecting nerve cells in the brain and spinal cord that controls voluntary muscles.

42 views • 3 slides